The Latest Breaking News from CLX

Amid rising worries over surging inflation, the Federal Reserve’s hawkish tilt, geopolitical uncertainties, and supply chain crisis, consumer defensive stocks have outperformed the broader market so far. However, not all stocks in this sector are well-positioned to dodge the market’s volatility. For example, lately, Clorox Company (CLX) and Estée Lauder…

Clorox Co (NYSE: CLX) shares are trading lower in Monday's after-hours session after the company reported financial results and cut its full-year earnings forecast.

Monday marks the last chance for investors to receive the next dividend payout from Clorox (NYSE:CLX).

Over the past 3 months, 9 analysts have published their opinion on Clorox (NYSE:CLX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

The shares of Clorox (CLX) have tumbled more than 14% in price on the company’s worse-than-expected earnings release and diminished full-year guidance. The company is currently grappling with inflationary pressures and supply disruptions, which are negatively impacting its margins. So, with Clorox’s 44-year history of consecutive dividend growth, is the…

Pulled from Benzinga Pro data, Clorox (NYSE:CLX) posted Q2 earnings of $72.00 million, an increase from Q1 of 49.65%. Sales dropped to $1.69 billion, a 6.37% decrease between quarters.

If history is any guide, there may be good fortune ahead for shares of Clorox (NYSE:CLX). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Credit Suisse analyst Kaumil Gajrawala downgraded Clorox Co (NYSE:CLX) to Underperform from Neutral with a $160 price target. The analyst thinks a large portion of Clorox's growth during the first phase of the pandemic came from categories that are now declining. If consumption continues to revert toward pre-pandemic levels, $500 million in company sales may…